Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion

Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion



This report is a brand new publication covering contract service agreements, across a range of different services and manufacturing scales. The number of contract service agreements secured serves as a primary indicator of a CMOs performance. Contract Manufacturing Service Agreements is critical for establishing an understanding of the overall CMO industry, the range of services provided and the features of some of the largest CMOs participating in the industry.

This report gives an important expert quantitative analysis on the contract manufacturing industry. Findings are based on the industrys most comprehensive databases of the CMO industry ( Databases of Contract Service Providers and Deals) this analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered. The 14 figures and 5 tables throughout the report illustrate major points and trends.

Scope

This report is required reading for -
- CMO executives who must have deep understanding of the novel approvals landscape to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

- Overview of CSAs and the levels of outsourcing associated with different services and drug type
- Detailed view of CDMO performance by CSAs and an assessment of their CSAs manufacturing scale from Deals database
- Manufacturing Agreements for different molecule types, RoA and by sponsor company market cap have all been assessed.
- Analysis of regulatory designations such as those with Orphan, Breakthrough or Fast Track designations and assessment of outsourcing


4 Executive Summary
5 Introduction
6 Contract Service Agreements Overview
7 Contract Services Offered and Manufacturing Scale
7.1 API Manufacturing Contract Service Agreements
7.2 Dose Manufacturing Contract Service Agreements
8 Contract Service Agreements by Therapy Area
9 Special Product Categories
10 Outsourcing by Sponsor Market Cap
11 CMO Performance
12 What It Means
12.1 Insights on Services Offered, Scale of Production, and CSA Relationships
12.2 Top CMO Players
12.3 Sponsor Market Cap Relationships to Outsourcing
12.4 Varying Levels of Public Disclosure
13 Notes on Methodology
14 Appendix
14.1 Appendix Tables
14.2 Bibliography
14.3 Primary Research - Key Opinion Leaders in this Report
14.4 About the Authors
14.5 Contact Us
14.6 Disclaimer

List Of Tables


Table 1: Contract Service Agreements Offering More than One Manufacturing Service, 2018-2020
Table 2: Scale of Therapy Area Contract Service Agreements, 2018-2020
Table 3: Sponsor Type by Services Offered in Contract Service Agreements, 2018-2020
Table 4: Most Active Sponsors by Contract Service Agreements, 2018-2020
Table 5: Contract Service Agreements, 2018-2020

List Of Figures


Figure 1: Scale of Contract Service Agreements, 2018-2020
Figure 2: Contract Service Agreements by Year, January 2018 - March 2020
Figure 3: Quantity of Services Offered Per Contract Service Agreement, 2018-2020
Figure 4: Quantity of Drugs Outsourced Per Contract Service Agreement, 2018-2020
Figure 5: Specific Services Outsourced in the Contract Service Agreements 2018-2020
Figure 6: Contract Service Agreements for Clinical-Scale API Manufacturing, 2018-2020
Figure 7: Contract Service Agreements for Commercial-Scale API Manufacturing, 2018-2020
Figure 8: Outsourced Dose Manufacturing by Molecule Type, 2018-2020
Figure 9: CSAs for Dose Manufacturing by Route of Administration, 2018-2020
Figure 10: Contract Service Agreements by Therapy Area, 2018-2020
Figure 11: Contract Service Agreements by Special Designation, 2018-2020
Figure 12: Contract Service Agreements by Sponsor Market Cap, 2018-2020
Figure 13: Most Active CMOs by Contract Service Agreements by Year, 2018-2020
Figure 14: Most Active CMOs by Contract Service Agreements by Scale, 2018-2020

Leading Pharmaceutical Contract Development Manufacturing Organizations

- Will the industry consolidate, decentralize, or undergo a bimodal transformation - How will the current trends affect the major market segments- Which companies will enter the market and which

USD 3500 View Report

Contract Pharmaceutical Dose Manufacturing Industry - Composition, Size, Market Share and Outlook, 2021 Edition

Contract Pharmaceutical Dose Manufacturing Industry - Composition, Size, Market Share and Outlook, 2021 EditionThis expert trend report is a comprehensive look at the finished dose contract manufacturing landscape in 2021,

USD 4995 View Report

Global Bakery Contract Manufacturing Market 2023-2029

Contract manufacturing is a business model where a company hires a manufacturer to produce its products or components. It is an outsourcing method for producing products by taking advantage of

USD 2250 View Report

Global Electronics Manufacturing Services Market Research Report 2023-2027

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Electronics Manufacturing Services Report by Material, Application, and Geography Global

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available